Historical Materialism and Social Development: Reconstructing a Marxist Theory in the Age of Contemporary Social Theory
Indonesian Journal of Advanced Research · 05.03.2026 · 5 (2) · 241-254
DOI: 10.55927/ijar.v5i2.16250 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indonesian Journal of Advanced Research, online erschienen am 05.03.2026. Verfasst von Ye Si Thu Aung. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This paper argues that Karl Marx’s theory of historical materialism remains partially valid and analytically fruitful when reformulated in dialogue with contemporary social theory. After clarifying social development, it reconstructs the core claims of forces and relations of production, class struggle, and modes of production. It examines failed empirical predictions, doubts about socialism or communism, objections to economic reductionism, and concerns about Eurocentrism. By placing historical materialism into conversation with structural functionalism, conflict theory, interpretive approaches, rational-choice and biosocial accounts, it proposes a non-teleological, multi-causal reconstruction retaining its explanatory core for digital capitalism and global inequality.
Zitieren
APA
Aung, Y. S. T. (2026). Historical Materialism and Social Development: Reconstructing a Marxist Theory in the Age of Contemporary Social Theory. Indonesian Journal of Advanced Research, 5(2), 241-254. https://doi.org/10.55927/ijar.v5i2.16250
Vancouver
Aung YST. Historical Materialism and Social Development: Reconstructing a Marxist Theory in the Age of Contemporary Social Theory. Indonesian Journal of Advanced Research. 2026;5(2):241-254. doi:10.55927/ijar.v5i2.16250
BibTeX
@article{Aung2026,
author = {Aung, Ye Si Thu},
title = {Historical Materialism and Social Development: Reconstructing a Marxist Theory in the Age of Contemporary Social Theory},
journal = {Indonesian Journal of Advanced Research},
year = {2026},
volume = {5},
number = {2},
pages = {241--254},
doi = {10.55927/ijar.v5i2.16250}
}
EUVIMED